Weight fluctuations in #MASLD and #T2D alter body composition and metabolic homeostasis and are associated with increased risks of adverse liver outcomes, cardiovascular events & mortality. onlinelibrary.wiley.com/doi/abs/10.100…

Discussing primary prevention for #cardiovascular disease for patients with #MASLD & #MASH from our UC San Diego Health Sciences expert Michael Wilkinson

The #MASLD –causing protein PNPLA3-I148M alters lipid droplet–Golgi dynamics PNASNews pnas.org/doi/10.1073/pn…

When they tell us it's called MASH/MASLD and not NASH/NAFLD now

Exciting day MASLD Research Center UC San Diego Health for our #MASH preceptorship.

Reviewing
💠diagnosis
💠risk stratification
💠treatment & management

in the setting of the new era of #MASLD where we now have pharmaceutical options 🙌

REVIEW | Lifestyle interventions in #NAFLD / #MASLD

nature.com/articles/s4157…

Diabesity & #MASLD are on the ⬆️in #emergingadults , but few AOMs are studied in this group. These pts face high depression & anxiety rates, needing tx with SGA known to exacerbate metabolic dysfx. Our study suggests topiramate as a safe & effective option! …ubs.pericles-prod.literatumonline.com/doi/10.1111/do…

#FattyLiver #MASLD
Incidence of Metabolic dysfunction Associated Liver Disease which used to be known as Non Alcoholic Fatty Liver Disease( NAFLD) cases are raising alarmingly across the globe. Eating Healthy and regular physical activity will give protection against it

#MASLD (Metabolic Associated Steatotic Liver Disease) is a new pandemic. With more than 20 drugs trialed and tested, satisfactory results eludes us.
#Resmitirom , the first U.S. FDA approved drug, can solve some of it.
Thanks Dr. Deep Dutta sir and his team for enlightening us

Veeral Ajmera reviewing #NoninvasiveTesting for hepatic steatosis and #fibrosis in #MASLD & #MASH MASLD Research Center at UC San Diego Health Sciences MASH Preceptorship

💠thresholds differ across studies- what cut points are highest yield?
💠know the limitations of each NIT

A gluten-free diet leads to significant improvements in liver and metabolic parameters, as well as patient-reported outcomes in #MASLD .
onlinelibrary.wiley.com/doi/10.1111/ap…

Day 4: #MASLD Making clinics work for patients 👏

⁦William Alazawi⁩ ⁦Prof Kamlesh Khunti⁩ ⁦Zurich Heart House (ZHH)⁩

Systematic review

Global pooled prevalence of NAFLD/MASLD in people with T2 diabetes 65%

Significant proportion have advanced fibrosis

cghjournal.org/article/S1542-…~

Phil Newsome

🔵SEMINARS
🗓️📌 Check out our seminars for the month of May! It will be a pleasure for us to host Fanny Jaulin JaulinLab and Catherine Postic Catherine Postic #womeninscience #cellbiology #cancer #masld
📢Stay tuned for more seminars at: bit.ly/4bibxTd

🚨🚨MAFLD vs. MASLD and all- cause and cause-specific mortality?🤔
🆕 study, 7811 participants; F/U: 27.1 Y.
➡️ Compared to #MASLD , the definition of #MAFLD demonstrated statistically significantly
📌 Higher overall mortality.
📌 Higher cardiovascular mortality.
✅ For improved…

There is no significant causal relationship between genetically determined #MASLD and gestational diabetes.
bmcendocrdisord.biomedcentral.com/articles/10.11…

William Alazawi eloquently describes management of #MASLD which = a multisystem condition
👉Fibrosis predicts outcomes
👉Not all pts with MASLD will develop adverse events
⬆️ associated #cardiovascular risk
- use statins = safe
🔥Change in clinician culture required; MDTs ✅

Systematic review showing
Global pooled prevalence of NAFLD/MASLD in people with T2 diabetes 65%

The majority of NAFLD/MASLD patients with T2D have NASH/MASH, and a significant proportion have advanced liver fibrosis
#NAFLD
#MASLD
#diabetes
#EndoTwitter

cghjournal.org/article/S1542-…

Prevalence and predictive features of #MASLD in #T1D

Prevalence of MASLD in T1D remains unclear. Here, Coco Fuhri Snethlage et al. investigated the prevalence and severity of MASLD in T1D, and assessed clinical features of importance for predicting MASLD severity👌

academic.oup.com/ejendo/advance…

⭐️今夜のスペース資料日本の国民病②
新・国民病ＴＯＰ３
❶機能性ディスペプシア
❷MASLD❸うつ病

❶胃の粘膜に異常がない。胃もたれ、早期満腹感、鳩尾の痛み
❷
MASLD：代謝機能障害関連脂肪肝疾患
NAFLD：非アルコール性脂肪肝疾患
肝臓に過剰な脂肪が蓄積して、肝炎と肝細胞の損傷が慢性的病態。